Amgen Efavaleukin Alfa
| abstract | A Phase 2, Multicenter, Dose-finding, Double blinded, Pla-cebo- Controlled Study to Evaluate the Safety and Effi-cacy of Efavaleukin Alfa Induc-tion Therapy in Patients with Mederatly to Severely UC |
| type of project | clinical studies |
| status | ongoing - recruiting phase |
| start of project | 2022 |
| end of project | 2023 |
| study design | Double blinded, 3 arms |
| responsible person | Prof. Dr. Stephan Brand |